Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on June 20, 2025

Intermap Appoints New Auditors
DENVER, June 20, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies Corporation (TSX: IMP) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that MNP LLP (“MNP”) have been appointed as auditors …

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was scheduled to be held on June 25, 2025, in light of the previously …

In 2025, users will use XRP, BTC, Dogecoin, USDC, etc. to earn $78,000 per day in PBK Miner
New York City, NY, June 20, 2025 (GLOBE NEWSWIRE) -- Cryptocurrencies such as Bitcoin are created through a distributed computing process called "mining". Miners (network participants) participate in mining to verify the legitimacy of transactions on the …

National Black Church Initiative Agrees with the US Supreme Court Ruling in the Youth Transgender Case
WASHINGTON, DC, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- The National Black Church Initiative (NBCI), a coalition of 150,000 African American and Latino churches that comprise 27.7 million churchgoers, believes that the Supreme Court got it …

Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering
LONDON, Ontario, June 20, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …

AGM Group Holdings Inc. Regains Compliance with Nasdaq Bid Price Requirement
Beijing, June 20, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
KUALA LUMPUR, June 20, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has entered into a securities purchase …

AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc …

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
BALA CYNWYD, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a …

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions
Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with …

PharmAla Files Preliminary Base Shelf Prospectus
TORONTO, June 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that the …

SUPRACONSCIOUS: The Genius Within You by Maria Olon Tsaroucha
“A groundbreaking fusion of quantum science, mindfulness, and performance to awaken your highest self.” SAN FRANCISCO, CA, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Internationally acclaimed author, educator, and consciousness pioneer Maria …

Sagteс Finalizes Strategic AI Acquisition to Accelerate SaaS Revenue and Multi-Sector AI Deployment
KUALA LUMPUR, Malaysia, June 20, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a next-generation provider of customizable AI and automation platforms, today announced the signing of a definitive Share Sale …

Marquis Who's Who Honors Pamela M. Cipriano, DNP, for Expertise in Health Care
Dr. Cipriano, a distinguished figure in the medical community, has dedicated over three decades to advancing health care practices and patient outcomes. THOMASTON, CT, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Pamela M. Cipriano, DNP, has been …

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules Nantes, June 20th, 2025, 7:30 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), publishes a “Questions and …

OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats, et le respect des règles de marché
OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats, et le respect des règles de marché NANTES, France, 20 juin 2025, 19 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; …

L'Agence spatiale européenne et Dassault Aviation ouvrent la voie à de potentielles collaborations.
COMMUNIQUÉ DE PRESSE 20 juin 2025 L'Agence spatiale européenne et Dassault Aviation ouvrent la voie à de potentielles collaborations. L'ESA et Dassault Aviation ont identifié un intérêt commun à développer une relation plus étroite pour favoriser …